New User? Click here to register

New drugs and options in MBC: Are there drugs that must be offered to patients in 2023?

Text generated by AI based on an exclusive interview, revised and reviewed by

Dr Jean-Philippe MINART, Cannes, France

October 20, 2023

Joseph GLIGOROV
MD, PHD Medical Oncologist, Paris, France

Role of the breast radiologist in MBC.
Naglaa ABDEL RAZEK
Radiologist, Cairo, Egypt
How can genomics power personalized medicine through pathology?
Aaron HAN
pathologist, Dubai, UAE
What is the significance of HER2 amplification and how does it affect the use of antibody-drug conjugates (ADCs)?
Joseph GLIGOROV
oncologist, Paris, France
Radiotherapy: Indications and progress in IDC.
Yazid BELKACEMI
Surgical Techniques and Innovations
Benjamin SARFATI